BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 310745)

  • 1. Cell-mediated immunity in mice vaccinated against malaria.
    Cottrell BJ; Playfair JH; De Souza BJ
    Clin Exp Immunol; 1978 Nov; 34(2):147-58. PubMed ID: 310745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of delayed type hypersensitivity responses in protection during chronic Plasmodium berghei infection as evidenced by homing of radiolabelled bone marrow cells and contact sensitivity.
    Wangoo A; Ganguly NK; Mahajan RC
    Jpn J Exp Med; 1990 Apr; 60(2):45-50. PubMed ID: 2200902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with a purified blood-stage malaria antigen in mice: correlation of protection with T cell mediated immunity.
    Playfair JH; De Souza JB; Freeman RR; Holder AA
    Clin Exp Immunol; 1985 Oct; 62(1):19-23. PubMed ID: 2933196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell-mediated immunity in malaria. I. The Ly phenotype of T cells mediating resistance to Plasmodium yoelii.
    Jayawardena AN; Murphy DB; Janeway CA; Gershon RK
    J Immunol; 1982 Jul; 129(1):377-81. PubMed ID: 6979570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular subsets involved in cell-mediated immunity to murine Plasmodium yoelii 17X malaria.
    Mogil RJ; Patton CL; Green DR
    J Immunol; 1987 Mar; 138(6):1933-9. PubMed ID: 3102605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination against cutaneous leishmaniasis in a murine model. I. Induction of protective immunity with a soluble extract of promastigotes.
    Scott P; Pearce E; Natovitz P; Sher A
    J Immunol; 1987 Jul; 139(1):221-7. PubMed ID: 3495599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage cytotoxicity in lethal and non-lethal murine malaria and the effect of vaccination.
    Taverne J; Treagust JD; Playfair JH
    Clin Exp Immunol; 1986 Oct; 66(1):44-51. PubMed ID: 3542317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium yoelii in mice: antigen reactivity of CD4- and CD8-bearing T cells.
    Lucas B; Engel A; Camus D; Haque A
    Cell Immunol; 1993 Aug; 150(1):59-71. PubMed ID: 8102089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-specific, interleukin 2-propagated T lymphocytes confer resistance to a murine malarial parasite, Plasmodium chabaudi adami.
    Brake DA; Weidanz WP; Long CA
    J Immunol; 1986 Jul; 137(1):347-52. PubMed ID: 2423609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two distinct types of non-specific immunosuppression in murine malaria.
    Lelchuk R; Playfair JH
    Clin Exp Immunol; 1980 Dec; 42(3):428-35. PubMed ID: 7011609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An in vitro assay for T cell immunity to malaria in mice.
    Weinbaum FI; Evans CB; Tigelaar RE
    J Immunol; 1976 May; 116(5):1280-3. PubMed ID: 774978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmodium berghei XAT: contribution of gammadelta T cells to host defense against infection with blood-stage nonlethal malaria parasite.
    Kobayashi F; Niikura M; Waki S; Matsui T; Fujino T; Tsuruhara T; Kamiya S
    Exp Parasitol; 2007 Dec; 117(4):368-75. PubMed ID: 17601562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity to Plasmodium Berghei yoelii in mice. I. The course of infection in T cell and B cell deficient mice.
    Weinbaum FI; Evans CB; Tigelaar RE
    J Immunol; 1976 Nov; 117(5 Pt.2):1999-2005. PubMed ID: 136472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociative effects of malarial infection on humoral and cell-mediated immunity in mice.
    Liew FY; Dhaliwal SS; Teh KL
    Immunology; 1979 May; 37(1):35-44. PubMed ID: 381176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells.
    Hirunpetcharat C; Tian JH; Kaslow DC; van Rooijen N; Kumar S; Berzofsky JA; Miller LH; Good MF
    J Immunol; 1997 Oct; 159(7):3400-11. PubMed ID: 9317139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive transfer of CD8+ T cells from immune animals does not transfer immunity to blood stage Plasmodium yoelii malaria.
    Vinetz JM; Kumar S; Good MF; Fowlkes BJ; Berzofsky JA; Miller LH
    J Immunol; 1990 Feb; 144(3):1069-74. PubMed ID: 1967271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunological response of CBA mice to P. yoelii. II. The passive transfer of immunity with serum and cells.
    Jayawardena AN; Targett GA; Leuchars E; Davies AJ
    Immunology; 1978 Jan; 34(1):157-65. PubMed ID: 342396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early lymphocyte trapping in malaria infections: a particulate antigen mediated phenomenon.
    Lewis-Hughes PH; Howell MJ
    J Parasitol; 1984 Jun; 70(3):391-7. PubMed ID: 6387079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is the delayed-type hypersensitivity observed after a low dose of antigen mediated by helper T cells?
    Milon G; Marchal G; Seman M; Truffa-Bachi P; Zilberfarb V
    J Immunol; 1983 Mar; 130(3):1103-7. PubMed ID: 6218199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunity to Plasmodium berghei yoelii in mice. II. Specific and nonspecific cellular and humoral responses during the course of infection.
    Weinbaum FI; Weintraub J; Nkrumah FK; Evans CB; Tigelaar RE; Rosenberg YJ
    J Immunol; 1978 Aug; 121(2):629-36. PubMed ID: 79610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.